B · Normal
[Haoyuan Pharmaceutical: Shareholders are planning to reduce their holdings by no more than 2.34% of their shares] On September 11, Haoyuan Pharmaceutical (688131.SH) announced that the company’s shareholders Shanghai Chenxiao, Shanghai Chenmai, and Shanghai Chenxi were due to employees’ personal qualifications. In order to meet the financial demand, it plans to reduce the total holdings of no more than 4.99 million shares of the company through centralized bidding within 3 months after 3 trading days from the date of announcement disclosure. The proposed reduction ratio shall not exceed 2.34% of the company's current total share capital.
Comments